Trials / Unknown
UnknownNCT04518202
Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy
Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy: a Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Aswan University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To compare the effectiveness of Transdermal Lidocaine for Pain Control During Diagnostic Office Hysteroscopy
Detailed description
hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of an intrauterine device or foreign body. Cervical ripening is made possible by the use of medication through different routes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lidocaine patch | 5% lidocaine patch applied at 6 hours before the scheduled office hysteroscopy. |
| DRUG | Sham patch | Sham patch containing no study medication applied at 6 hours before the scheduled office hysteroscopy. |
Timeline
- Start date
- 2020-09-01
- Primary completion
- 2021-08-31
- Completion
- 2021-09-30
- First posted
- 2020-08-19
- Last updated
- 2020-08-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04518202. Inclusion in this directory is not an endorsement.